• 'It Is Time to Stop Vaping' -Kansas Reports 6th U.S. Death Linked to Mystery Illness A Kansas resident was the sixth person to die in the United States of a mysterious respiratory illness related to vaping, state officials said on Tuesday, as public health officials scrambled to understand a nationwide health problem.
  • Lilly's Targeted RET Drug Shrinks Tumors in Lung Cancer Trial Eli Lilly and Co's LOXO-292, a experimental cancer drug the company acquired in January as part of its $8 billion takeover of Loxo Oncology, shrank tumors in nearly 70% of advanced lung cancer patients whose tumors carried specific abnormalities in the RET gene.


  • Are the History and Physical Coming to an End? In this new era of 'multiomics,' physicians ponder the future of the traditional patient encounter.
  • 7 Best Ways to Deal With a Hypochondriac Patient There's a fine line between humoring an anxious patient and diagnosing an illness anxiety. Here are key strategies to effectively treat patients who may needlessly fear they harbor dread diseases.